Company Growth (employees)
AbbVie was founded in 2013 and is headquartered in North Chicago, US
Key People at AbbVie
Richard A. Gonzalez
Chairman of the Board and Chief Executive Officer
AbbVie Office Locations
AbbVie has an office in North Chicago
North Chicago, US (HQ)
1 Waukegan Rd
AbbVie Data and Metrics
AbbVie Financial Metrics
AbbVie's revenue was reported to be $25.6 b in FY, 2016 which is a 12% increase from the previous period.
USD
Revenue (FY, 2016) | 25.6 b |
Revenue growth (FY, 2015 - FY, 2016), % | 12% |
Gross profit (FY, 2016) | 19.8 b |
Gross profit margin (FY, 2016), % | 77% |
Net income (FY, 2016) | 6 b |
Market capitalization (28-Jun-2017) | 116.1 b |
Closing share price (28-Jun-2017) | 72.4 |
Cash (31-Dec-2016) | 5.1 b |
EV | 147.8 b |
AbbVie's current market capitalization is $116.1 b.
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 18.8 b | 20 b | 22.9 b | 25.6 b |
Revenue growth, % | 6% | 15% | 12% | |
Cost of goods sold | 4.6 b | 4.4 b | 4.5 b | 5.8 b |
Gross profit | 14.2 b | 15.5 b | 18.4 b | 19.8 b |
Gross profit Margin, % | 76% | 78% | 80% | 77% |
Operating expense total | 13.1 b | 16.5 b | 15.3 b | 16.3 b |
Interest expense | (278 m) | (391 m) | (686 m) | (965 m) |
Income tax expense | 1.2 b | 595 m | 1.5 b | 1.9 b |
Net Income | 4.1 b | 1.8 b | 5.1 b | 6 b |
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 9.6 b | 8.3 b | 8.4 b | 5.1 b |
Accounts Receivable | 3.9 b | 3.7 b | 4.7 b | 4.8 b |
Inventories | 1.2 b | 1.1 b | 1.7 b | 1.4 b |
Current Assets | 17.8 b | 16.1 b | 16.3 b | 16.2 b |
PP&E | 2.3 b | 2.5 b | 2.6 b | 2.6 b |
Goodwill | 6.3 b | 5.9 b | 13.2 b | 15.4 b |
Total Assets | 29.2 b | 27.5 b | 53.1 b | 66.1 b |
Total Debt | 3.9 b | 4.3 b | 29.6 b | 36.8 b |
Current Liabilities | 6.9 b | 11.4 b | 10.9 b | 9.8 b |
Additional Paid-in Capital | 3.7 b | 4.2 b | 13.1 b | 13.7 b |
Retained Earnings | 1.6 b | 535 m | 2.2 b | 4.4 b |
Total Equity | 4.5 b | 1.7 b | 3.9 b | 4.6 b |
Debt to Equity Ratio | 0.9 x | 2.4 x | 7.5 x | 7.9 x |
Debt to Assets Ratio | 0.1 x | 0.2 x | 0.6 x | 0.6 x |
Financial Leverage | 6.5 x | 15.8 x | 13.4 x | 14.3 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 4.1 b | 1.8 b | 5.1 b | 6 b |
Accounts Receivable | 681 m | (172 m) | (1.1 b) | (71 m) |
Inventories | (56 m) | (203 m) | (434 m) | (38 m) |
Accounts Payable | (426 m) | (193 m) | 1.5 b | (1.2 b) |
Cash From Operating Activities | 6.3 b | 3.5 b | 7.5 b | 7 b |
Cash From Investing Activities | 879 m | (926 m) | (12.9 b) | (6.1 b) |
Short-term Borrowings | (601 m) | 12 m | (19 m) | (29 m) |
Dividends Paid | (2.6 b) | (2.7 b) | (3.3 b) | (3.7 b) |
Cash From Financing Activities | (3.4 b) | (3.3 b) | 5.8 b | (3.9 b) |
Income Taxes Paid | 1.3 b | 498 m | 1.1 b | 3.6 b |
| USD | Y, 2016 |
|---|---|
EV/CFO | 21 x |
Revenue/Employee | 1 m |
Debt/Equity | 7.9 x |
Debt/Assets | 0.6 x |
Financial Leverage | 14.3 x |
AbbVie Market Value History
AbbVie Median Salaries
Source: 442 public H-1B filings from AbbVie
